In Your Pants with Dr. Susie G - Muscle tone pelvic pain in men
Episode Date: August 4, 2023It's human nature to get excited by the latest and greatest treatments, from outer space to muscle tone pelvic pain, we're captivated by scientific advancements. But this enthusiasm has a dark side, c...ausing many clinics and patients to exchange simple and effective strategies for flashy new treatments that come with a hashtag. Dr. Rachel Worman is a licensed physical therapist (PT) who has experience in acute care physical therapy and extensive dual training, clinical and teaching experience in musculoskeletal and pelvic health physical therapy. After 13 years of clinical practice, Dr. Rachel earned her PhD with a focus on pelvic health outcome measures and male pelvic health. We cover topics such as: 1:15 What to call it? Hypertonic pelvic floor, overactive pelvic floor, tight or non-relaxing pelvic floor muscles? 8:55 How and who treats pelvic floor dysfunction 10:30 Educating patients with pelvic pain and choice of language 16:37 Uncertainty and the biopsychosocial model 17:40 Pain and hypertonicity 20:00 ICS and reasoning scale 36:00 EMG biofeedback for pelvic floor physical therapists 45:00 Internal and manual therapy for male pelvic pain 51:30 Psychosexual measures and sleep, hormonal, or musculoskeletal factors 55:00 Bridging research with clinicians on social media Pelvic floor physical therapists and patients have to be mindful of the influence that media (including social media and speakers at conferences) has on trending treatment ideas and how common it is for a 10-second video on social media to hijack a patient's treatment plan, simply because it wasn't a good fit. There's no one-size-fits-all treatment strategy for pelvic pain, which is why there many treatment strategies. Through critical evaluation, clinicians must determine the most appropriate and effective treatment strategy, or combination of strategies, for that single patient. Dr. Rachel shares how important it is for clinicians to be flexible, individualized, and science-based, and to avoid getting caught up in clinical habits of using one hallmark treatment for all patients. In such a difficult field, where all the measures we have for tone are problematic, these generalizations and trending treatment ideas, while good for marketing, ultimately delays effective treatment and harms patients. It's necessary to prioritize the knowledge of evidence-based practices and personalized care to ensure optimal outcomes for patients. RESOURCES: Free sex and pelvic pain resources https://drsusieg.com/resources-for-pelvic-pain-in-men Online Pelvic Pain Relief Program for Men https://drsusieg.com/pelvic-pain-in-men-online-program Research paper on resting pelvic floor muscle activity https://academic.oup.com/ptj/article-abstract/102/7/pzac059/6585840?redirectedFrom=fulltext&login=false#no-access-message CONNECT WITH RACHEL WORMAN: Website: https://www.researchgate.net/profile/Rachel_Worman Instagram: @pelvic.fiiit.facts Twitter: @rachel_worman CONNECT WITH ME (DR. SUSIE): Website: https://drsusieg.com/ Instagram: https://www.instagram.com/dr.susieg/ ___________________________________________________________________________ Disclaimer: This information is not intended to substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a healthcare professional with any questions you may have regarding treatment, medications/supplements, or any medical diagnoses. This information is intended for educational purposes only and is in no way to substitute the advice of a licensed healthcare professional. #tightmuscles #pelvicpain #pelvicfloorphysicalthearpy
Transcript
Discussion (0)
you're listening to the in your pants podcast i'm your host dr suzy gronski your penis friendly
pelvic health physical therapist sex counselor and educator helping you get in the know down below
Hi friends, Dr. Susie G here and welcome to another In Your Pants podcast.
On today's show, we are going to be debunking the myths and misconceptions around quote,
air quotes here, tight, overactive, non-relaxing, hypertonic pelvic floor muscles.
So many names with no conclusive data to support either of them.
And to help debunk these misconceptions that are running rampant on social media these days
is researcher Rachel Worman.
Rachel and I dive into the depths of her research to determine whether greater tone or higher
activity equals pain and is the same applicable with pain causing greater tone or higher activity.
You don't want to miss this episode.
So before we dive into the juicy parts of today's show, let me formally introduce Rachel
Werman and her fantastic accolades here.
So Rachel is a licensed physical therapist in the United States who has extensive dual
training, clinical and teaching experience in both musculoskeletal and pelvic health
physiotherapy.
She has worked as a musculoskeletal and pelvic health provider in the private outpatient setting
and most recently held a senior physical therapy position as a pelvic health provider in the
Women's Health and Neurology Clinics of a large medical group in Northern California. She has
held part-time and adjunct faculty positions at both the California State University at Fresno
and Sacramento as well as a clinical lecturer position at the University of California at
davis school of medicine the division of pain medicine she received her bachelor's of science
in biopsychology with an emphasis in visual neuroscience and a minor in exercise and health
science from uc santa barbara in 2002 her master of physical therapy from csu fresno in 2007 and
doctorate in physical therapy from the joint program at uc san francisco and csu fresno in
2008. In 2019, she was awarded a full scholarship from the University of Queensland for a PhD
candidacy as a result of her advisors, Paul Hodges and Ryan Stafford, being awarded a large
NHMRC grant titled Efficacy of a Personalized Pelvic Floor Muscle Training Program on Urinary
Incontinence After Radical Prostatectomy, a Randomized Clinical Trial with Embedded
Physiological Studies, where she is working on the Embedded Physiological Studies. Her research
focuses on the study of pelvic health outcomes measures and male pelvic health, and her thesis
was confirmed in 2020 with the working title, Toward an Understanding of the Role of Pelvic
Floor Muscle Tone in the Examination of Male Pelvic Health Conditions, Investigation of
concepts of greater tone and a preliminary framework for down training. So she is certainly
someone to keep on your radar for all things clinical research for men's pelvic health.
I hope you enjoy today's show. Rachel, thank you so much for being on the show today.
Thanks for having me. Well, we're gonna we're gonna dive right in because this is a topic that
is certainly very passionate, a passion of mine, certainly having to deal with the pelvic floor,
but also this, your, your research in the male pelvic health realm is this such an amazing
conversation to have with you and to go over your, your most recent systematic review that came out
about tone, pelvic floor tone and overactivity and et cetera. So there's a ton of hype on social
media right we we no argument there about how you know your pelvic pelvic floor tightness
overactivity hypertonic in air quotes non-relaxing in air quotes um cause all sorts of problems
right like pain sexual dysfunction urinary issues bowel issues etc so based on your most
your research and your most current systematic review what language should we really be using
to describe the state or the health of pelvic floor muscles and why?
Yeah, that's a really great question.
And so this systematic review, which is regarding the evidence for increased tone
or overactivity of the pelvic floor muscles in pelvic health conditions,
was designed to look at outcome measures and to look at study methods and then we also pieced in
terminology and that's because we're not speaking the same language and it's problematic and
it was one of the things that led me to design my thesis in the way that I did
um so let's tackle hypertonic first um i think in clinical circles it's long been discussed that
this is an inappropriate term you've probably heard that right uh-huh because the majority
of pelvic health cases are not cases with central nervous neurologic problems such as a spinal cord
injury which would be the most appropriate context for this term yet we continue to see and hear this
term all over social media as you mentioned and from self-proclaimed guru pellet pts who are
um who are proclaiming that they are evidence-based and before our systematic review came out
there was actually the international continent society um came out with a terminology report
that also suggested that we not use the term hypertonicity
um and so this systematic review actually found that hypertonicity is the most commonly used
term in the clinical literature um but never was it used in the clinical literature in the
context of neurologic pathology interesting um and so um i think that this is um it's a problem
because it's actually inaccurate and again you know not just our systematic review but reports
prior to this have have stated that and we've discussed it for a long time so at this point
anyone using this term in the absence of neurologic pathology is um currently not practicing
evidence-based practice that's just full stop in the mid-2000s there was an effort led to reduce
the use of this term with a substitute term, overactive. In fact, there was a textbook by
Tali Rosenbaum and Anna Padua that was published in 2016 called the overactive pelvic floor.
However, this is also an inaccurate term. So first, if we think about tone, it is made up
of two muscle properties, the active tone, which is the nerve activity that causes the muscle to
contract and passive property which is essentially all the other content of muscles that are active
so the connective tissue the water content etc that give us resistance when we push on muscle
so overactive is a term that is best used when we have used a measure of the active component of
tone and the only measure to do that is emg there's also been a trend for therapists i think
to move away from using EMG. Problematic. So if EMG was not used as a measure, we cannot use a
term that describes muscle activity. So if you've not used EMG, we can't say overactive. And we saw
a lot, the term overactive frequently used when say something like digital palpation was the
measure, not EMG, which is technically inaccurate. Terms like non-relaxing pelvic floor do not make
sense when describing a muscle that requires at rest a certain amount of tone to maintain
continence. Makes sense, right? But if we say non-relaxing, well, we don't want these muscles
to completely be turned off so unless we want to wear pampers all the time so um
in some context though non-relaxing may be an appropriate term for instance if we're measuring
function and usually this is found in the urologic and the colorectal literature so if the assessment
we make is during bowel or bladder voiding in that case we want the muscle to turn off fully
and relax fully to allow for passage of bowel or bladder content.
So it might be appropriate to use it there.
Now, from our systematic review, we now know that there is not very much normative data.
So terms recently proposed, and this was also by the ICS terminology document,
such as increased tone are also inaccurate.
So in the absence of normative data, we can't state that something is increased
as we have no normal values to compare that against.
We also cannot use that term on an initial evaluation
because we don't have prior values for the previous test.
Makes total sense.
Right.
So the best term to use at this time is greater tone
because it can describe the comparison of an individual to another individual.
And that's based on our reference as a clinician.
This person had greater tone than this person.
I see. I see. And that's within, so as a clinician doing an assessment, that clinician is using their subjective experience with previous individuals, not just that particular individual, or is it just within that individual and assessing whether tone was greater or not with reassessment?
It can be both.
Okay.
Yeah. And, and if we look at evidence where there is a healthy comparison, we can also use that term greater tone. And if we are using EMG, and in the absence of good and convincing normative data for EMG, we can say higher activity.
um so this activity was higher than that activity and higher is a better description
than greater just because when we're looking at an EMG we're looking at lines going higher
it's simple I like to keep things simple
I mean the thing that's the thing that's really fascinating Susie about this is that um it was
really complex um to arrive at that but now that we've now that we've arrived at at this new
knowledge it's like oh duh this is so simple why didn't we think about this why haven't we been
speaking this language all along but um anyway
it totally makes sense and i think this this change in some cohesiveness with language and
actually having biologically plausible and also some data to back up what it is that we're
actually examining, assessing, and treating. There's a lot of confusion there, right? Because
depending on how I'm defining what I'm defining when I'm evaluating someone, then my treatment
offerings are going to be based on my preliminary definitions and what I think those mean and what
I think I'm actually doing? And is it actually, are we actually changing what we're changing or
what we're assessing, right? There's just a lot of confusion. We're so excited to get to the next
latest and greatest treatment. And so we've really bypassed the basics. I think sometimes,
you know, we're taught the basics and then we think, oh, that's really basic. So I'm going to
move on to this other um advanced treatment concepts and we sort of we throw it we forget
that right but it's always good to go back to the basics and um and really consider we know these
things but we're we're skipping over it um unfortunately not thinking through our assessments
and what it what it means and what our measures are actually telling us actually exactly exactly
Now, this language, you know, as a clinician, I can understand this and this makes sense
to me.
But when I then, when we then go to explain this to the patient, right, because they're
in pain or they have some sort of, you know, dysfunction, certainly, and they're wanting
to get help, how, what is your advice on like the language that we use with our patients
and how might that influence their treatment outcomes, knowing what you know now?
yeah um I think that's a really important conversation so I think in terms of language
language with patients the best approach is honesty and education first of all um and I
think that the certainty with which we speak or advertise and especially on social media sometimes
is unwarranted and and misleading and we have to be careful um generalizations that are made
on social media? Um, well we know better now. Um, and I think that we just went through this
in other contexts. So, um, I, I think what, what I see in terms of the tone terminology is
hypertonicity causes pain. Right. And that's a very, that's a very common one. And as we just
discuss hypertonicity is not factually accurate term and and those generalizations and that
language is problematic because well we just went through this as I said in other contexts that
treatment is between a patient and a provider and if we throw it out there as a you know one
size fits all um then then it's problematic because what happens when we're we are so certain
in the absence of evidence and a basis for that certainty and then we the the patient
does not get better what do we do then we were so certain and the patient was certain and was
almost guaranteed that they're going to get a certain result and it didn't happen um so i think
it can be a little bit damaging um and frustrating and it just repeats the cycle and a frustration
for the providers for the patients some of my colleagues down here at the university of
queensland um are working on the sociologic aspects of the biopsychosocial model so putting
the social back into biopsychosocial and um the words matter and and they just put out a paper
recently um talking about uncertainty in clinical practice and it's really fascinating but it turns
out that patients seem to actually prefer and be okay with the fact that we're uncertain as long
we put it out there in an honest way. So if we can humble ourselves to that uncertainty,
I think we'll get further. Wise words. Wise words. Yes. Yes. So speaking of,
you mentioned this briefly in your discussion just now about, well, does greater tone or
higher activity necessarily mean pain in all situations what are your thoughts we don't know
and not necessarily so that simple answer right i love it i love how simple you are rachel this
is great because my brain can only handle simple okay this is great so what i'm hearing is
So someone might have experienced pain in their body or in their pelvis and have no signs of greater tone or higher activity, but still experience pain and vice versa may be also true as well.
Right. Yes.
So if we find tenderness on palpation, it doesn't necessarily mean higher activity.
And this assumption is made all over the clinical literature.
and clinical practice um if there is pain it is assumed that there is tone um this comes up
well what you'll see in in the clinical literature is um the measure that was performed
um was pain on palpation and then the clinical output or interpretation is trigger point
and trigger points by definition has greater tone as a background and so so there's an assumption
made and it may not actually be the case one does not equal the other they may coexist
but they also may exist independent of each other um so the best way to find out
is to measure both so again we just keep it simple measure pain measure tone
what's there just don't make an assumption palpate the muscle using the reasoning scale
to grade tone then use the numeric rating scale to measure the pain
can you briefly oh sorry but rachel can you briefly uh walk us through the
is it reason scale reason scale the reasoning scale yes um so the reasoning scale is the only
palpation measure that measures resistance to passive stretch which is
well so um let me just back up a little bit so when when we are measuring um stiffness
from a physics standpoint it's a resistance to passive stretch by a tool that gives us a force
output newtons per meter our finger does not give us that measure force we think so but
it doesn't so we push into a muscle and then our brain interprets that based on our experience
so so what we're measuring is is actually not stiffness we call it that sometimes
um it's it's tone based on our subjective interpretation so but the the reason scale is
is um basically we push into the muscle and we measure our we give that interpretation of of
that resistance to passive stretch. And we grade it on a scale of zero is normal, plus one, plus
two, plus three is greater tone and minus one, minus two, minus three is lesser tone. So it's
a seven point scale. And the reasoning literature also has a scale for the external anal sphincter
muscle, which is a three point scale. Zero is normal, plus one is greater tone and minus one
is less. The reliability of the seven point reasoning scale is somewhere in the range of
0.2 to 0.5. So it's moderate, has moderate reliability. There are a lot of different
scales that are in the literature that are sort of invented by the researchers and they're not,
they haven't been tested to be reliable the recent terminology paper by the international
continent society has suggested that we just used increased tone normal and decreased tone
and that's because of a paper that came out i think in 2019 by melissa davidson
where they actually looked at the reasoning scale and found out on uh with a lot of different
measures, um, that it may actually not be that accurate, but it is the most accurate thing that
we have, unfortunately. Um, the nice thing about the reasoning scale is that we can superimpose it
onto the ICS scale, which is, um, I think it's necessary. Um, depending on the clinical setting
that you're practicing, if you're working with insurance companies and you need to be able to
show continued progress, then we, um, it's nice to have that extra three point scale, um,
rather than, you know, just going from increased tone to normal. Cause that probably doesn't happen.
Um, and I guess I could say also that, um, from the Melissa Davidson paper,
what therapists are really good at is knowing when there's really, really high tone and really,
really low tone. So the reason that ICS did that in part, I believe, is because
we're not as good at distinguishing between that plus one, plus two, plus three. So we do have to
be careful. So I do say that with some caveat. No, that's super helpful because at least that
give some guidance of having some sort of consistency with what we're assessing and
the meaning behind what we're assessing. And also helpful to know that a lot of the scales
that one might read in clinical research were created by the researchers in order to defend
their research, essentially, or to make sense of their research, maybe. Maybe defend is a big word
and I shouldn't use that word. Right. And I would say clinical researchers. And, and so sometimes
what you'll see is that you've got a research team and you've got some pelvic health physical
therapists that are sort of influencing that. And so. That makes sense. I mean, that makes sense.
Yeah, that makes sense. But, but I'm glad they're having this conversation about what to look for
when we're actually reading papers, when we're, you know, looking at things on social media and
reading and health literacy and how accurate that is and updating our language and updating
our knowledge. Because I think it's freeing too, you know, because a lot of the people I work with
too are sometimes, you know, they've been told a lot of things about their bodies that I think
prevent them from full recovery because it's it's almost an unattainable goal of my pelvic floor
muscles don't relax or my pelvic floor muscles are you know there's tone there's hyper tone in
there there's too much you know it almost it can be very paralyzing i think yes yeah my opinion
so okay there's an interesting paper and i know we were speaking um before we started recording
about the Yanni paper from 2022. And it's, it's very rare to see research for, for men's health,
especially in this, in this way, the researchers compared men with chronic pelvic pain to a
healthy control. It's a good start to those without pelvic pain. They did use the surface
EMG internal electrode. Awesome. Also great. I thought it was very easy to, to kind of follow
the research and things um but it but what what not shocked me really but what was surprising is
that when i saw their data and you and they compared the controls with both conditions that
they were they were testing the at rest condition and then the rest after contraction condition
the healthy controls EMG or muscle activity was higher than the the the pelvic pain group and
and you know that's almost counterintuitive to everything that we're told right like again
thinking that higher activity or greater tone equals more dysfunction or more pain or more
symptoms etc and this was almost saying well that that there's a mismatch there so I would love to
hear your thoughts about this paper. And yeah, I would love to hear your thoughts about this paper
and their findings. I think that first of all, this paper is the first paper to provide
convincing evidence because it uses a valid measure. The EMG, as you mentioned, has that
healthy comparison, as you mentioned, and there's no application issues. So what we mean by that,
And this is how we judge papers in the systematic review, in our systematic review.
No applications in the case of EMG means that we want to see that the data was normalized.
And normalization of EMG data is really important if you are comparing between cases or between days.
And they did all that, and it's great.
In fact, the paper would have been in the systematic review if it was published a little bit earlier.
I figured as much. I figured as much. Yeah. So it's really nice in that sense. I think one of my criticisms of the paper is that it only uses EMG, so there's not a combined measure there. And so we don't have an understanding. And I think to your question, well, they did find that the other nice thing about this paper is that,
And we haven't seen this a lot in papers yet, is that they actually took the eligibility questionnaires and they actually delineated out the specific detail.
So in other words, they were able to, um, look at the men who had more specifically
ejaculatory pain, for instance, um, compared to, I think it was testicular and maybe
interrectal pain.
Um, and per the NIH CPSI, I think was the tool they use.
Um, so, so that's really nice.
That's really important.
That's something I'm really interested in, in seeing.
Um, and so the men with the ejaculatory pain actually did have higher levels.
Um, but, but the, I guess to answer your question, um, I, I've already sort of answered it in,
in that, um, if the tone, if the EMG activity is lower, um, but there's still pain there,
what in the heck are the combined measures showing us so what is the passive stiffness
looking like and we can't measure there's no measure for the passive property of tone
it's sort of a relative concept that you would a judgment that you would make
based on having tested two things active and passive and if there's not active there then
but there is positive findings on the combined measures, then you can potentially make that
judgment. And combined measures, just for clarification, is when you're using an active
measure like a surface EMG that actually gives you an output of data and, for example, digital
palpation. Good question. So combined measure means that it can't differentiate between the
active and passive properties. So when we do digital palpation and we, um, make a judgment
that there's a greater tone, we don't know if it's coming from muscle activity or from
connective tissue stiffness, for instance. Okay. Um, when we first started doing this review,
we were going to judge out all the measures by, um, passive or active. And then we're kind of
going, wait a second, that doesn't make sense. Well, we were going to call it mechanical.
But that didn't really make sense because all these measures, all measures except for EMG
are giving you an output that is a combination. That's why it's called combined.
I got you. Okay. Okay. Of active and passive components to muscle.
Right. So that's why it's really important. And Millie Moran did this
um, in one of her papers where she was using dynamometry, which is the combined measure.
But what she did is she put EMG electrodes on the tip of the dynamometer, which is basically
the dynamometer is kind of like chopsticks that they, um, place into the vaginal canal.
We can't use this in men or we don't use this in men at this point. Um, but it, um, it pushes
into the muscle. And so what they did with the EMG on the tip of the, of the,
speculum the dynamometry speculum is they put this emg plate and then they can push into the muscle
wait for the muscle activity to die down and then do the passive measure so that's the closest that
we have gotten to do actual passive measure wow wow yeah that sounds very complicated
it does i mean just to get this data and i hope people appreciate the all the detail that goes
into being a researcher uh when you do it well you know i mean there's so much thought there's
so much detail there's so many questions there's no so many paths to go down um to really uh yeah
to really have substantial um you know evidence or some sort of um conclusion you know to make from
everything you've gathered so there's certainly a lot of problems solving and creativity and
getting these measured these are some of the most difficult muscles to measure in the body they're
very problematic uh for a research standpoint so definitely definitely do you get a lot of folks
who um i i i always wondered this that folks who volunteer for studies that have to do with pelvic
floor is is is it easy to find folks to sign up for these studies well so
um no um there there are a couple of factors um there you know we're we're testing male
participants and i've had this discussion with a number of people i'm i'm doing this work
in this research in australia so um there's it's a the i would say that the male participants it's
little bit harder to break into um the men's health community here um it's just not
it's not discussed well in the United States but it's really not discussed
a lot here either and so it has been a challenge um there was one of the studies that I did was
done, um, in females, um, prior and there was plenty of willing participants. So, um, there
are, there do seem to be some barriers. Um, I had this idea that, oh, well, once we get past the
healthy controls, then, you know, there'll be plenty of patients to test. And I think that
there are, but the willingness, and I thought that there would be some willingness there. Um,
And because my experience in working with men over the years is that they're very keen to help the cause, because there is not a lot that we know about this population, unfortunately.
And so, but it's been a challenge in men with pelvic pain as well.
So we'll see.
yeah so for all those men listening and if this is your experience please connect with your
researchers and help your your your fellow man you know um in that sense right so that's my
that's my plug for the for the for the research push um yeah let us help you better right like
let us um really do the research because it is it is a huge gap with male pelvic health and pelvic
pain research for sure when compared to their counterparts. And also a huge gap in the
transgender community and non-binary folk and gender expansive people. So yeah, lots of shoes
to fill and so grateful for researchers like you and clinicians like you who take to, you know,
step into this courageously with a lot of compassion and empathy for the people that
um, you're helping. So thank you. And thank you to your team.
So, okay. So one last question here. Well, actually a couple, a couple, I have, I have two,
if that's okay. The one going back to surface EMG, um, so numbers, numbers, and I, I'll be honest,
I'll be the first one to say that I am one of those clinicians that have threw the baby out
with the bath water when it came to the EMG, right? The biofeedback. No, no, no, that's crap,
right? And I am actually, I'm considering bringing that back after having this conversation with you,
after reading your research, after watching your webinars, because I think it has merit,
but the narrative around the use of it has changed. And I think that was a really important
piece for me is, okay, this makes more clinical sense. And this definitely feels like it's
biologically possible and based in science. Um, whereas the narrative before was very different.
So I, there is a, how do we know you had mentioned your webinar that there's, there's,
there's a number out there of two microvolts for muscle activity with an EMG. But then you
had mentioned too, that there are other studies that say average or quote unquote normal is maybe
could be six to nine uh millivolt so what are your thoughts on do we how do we hold do we hold
lightly to those numbers can we be fairly confident in in two i don't know i don't know what to think
about that i think we need overall more participants um to come up with that sort of
normative data um the white paper which was the original one that if you trace that back where
that to i mean you you've heard this in coursework from the get-go i'm sure two two microwatts oh
yeah um and um i so so that paper is not super convincing um and there's a couple of interesting
findings in that paper. Um, one is that there's a couple of images and, uh, explanations of images
that are mixed up, which just could be, um, just publication snafus. Um, the EMG
image there's a image of the eung in there is actually um hand traced um so if you so it's
just a little bit sketchy and it may be that because of how um you know from the date of
that publication and how we did you know published images that that was why they did it but but what
you'll see on the image it's really fascinating is that so so emg is measured over time so
there's a there's a spike in the emg that actually comes back in time oh that must be
and so yeah it's just questionable um at any rate um and it could just again be a hand tracing to
to make the image better and it just wasn't done well but um yeah and then the other study is more
recent um probably a little bit more convincing but still you know relatively small population
of subjects um and i didn't oh so this new paper showed also an average of two
no so the newer paper is the one that showed closer to six okay okay yeah it's uh that's
That information is in the, I think it's in the discussion section of the systematic review.
And I'm sorry, I don't remember the numbers off the top of my head or the author at the moment,
but I think it's about six to nine was the resting data.
I think you had mentioned that.
Yeah.
And then there's a number of authors that have used, I think it was one to two,
um, microvolts in it. Um, yeah, I think it was microvolts, not millivolts. Um, microvolts in
was the resting data for women. And then for men, it was two to three. And I might have the male
and female reversed on that. Um, but that was based on clinical expertise. And so it's just
and judgment call. So we have to be careful there. Right. Right. I got you. Okay. Okay. So
again, it sounds like to me, how I'm understanding this is it should always be applicable to the
person or brought back to the person that you're working with just to connect that back with,
is this biologically possible that, because we don't know prior to that person not having pain.
I mean, we didn't measure that before. So I don't have that data, right? I don't have anything to
really compare to and it kind of makes it challenging when there's such a wishy-washy
inconclusive like well what is kind of normal or average that i can actually go over to make
a conclusion that you know this number equals uh pathology or dysfunction or you know because
because we don't know that that's the case at all actually um sure and and to add to the complexity
You know, the clinical EMG tools that we have do not provide us with the data that we need to do normalization.
So comparing one patient from day to day, visit to visit, is problematic.
um it is more um we can do a comparison from an early part in the same day to a later part so
you know pre-treatment and post-treatment on the same day um and these are some things that
i've had some discussion with some of the people working on the seed project which is the um isek
group from the ISAC group, which is the International Society of Electro-Kinesiology.
And I'm trying to put a bug in their ear to help out the pelvic floor clinicians,
because we are the ones that are really utilizing EMG the most,
even though we've sort of gotten away from it.
And I agree with you, you know, I use it a lot.
I was a heavy utilizer of it up front, but
time in the clinic I mean there are all these factors but like you said now now that I'm looking
at it differently I think one of the criticisms is kind of centered around this is what you hear
a lot in social media oh my gosh I just saw this patient who was at this clinician and all they did
is put him on biofeedback and leave the room and have them watch this and try so so it's really
the complaints seem to be centered around the treatment aspect of it and we were and we're not
just so we're thinking about it in terms of treatment but we're not really doing a good job
considering what what it means from an assessment standpoint and a lot of times with EMG you know
you you do the assessment and they're well they're hooked up so let's there's some findings there so
let's maybe just kind of work on some things right and there's certainly times where we use a lot of
EMG or pediatric cases where I think it's really important, our spinal cord injury patients,
that's really important. But I've got kind of got away from it in other instances, except for just
like every now and again, you're like something I need to, I'm not getting at the answer all these
other ways. So let's spend the time to do this. But I guess I just wonder, you know, if we're
really considering the muscle properties in this way, would we arrive at a better conclusion
earlier even though it's time consuming would we arrive at that conclusion earlier and get to the
outcome that we want for the patient sooner and that's that's something that we need to to look
at now right and so that that that sounds like knowing okay so so what's influencing
a particular process right um or contributions to um this very protective uh you know a pain
state pain sensitivity etc so this goes back to a question i had here about pelvic therapy being
very heavily manual therapy focused and doing internal work and and so forth um does this
research that you, you know, in the research that you know and what you've learned so far,
has that changed how you utilize manual therapy? Well, let me just kind of jump off your last
question. I was just mentioning that EMG is really problematic, but actually
all the measures that we have for tone are problematic. And the same people who are really
critical of EMG in in our profession are the highest users of digital palpation
and digital palpation is the least um reliable and it's certainly not valid measure that we have
of tone um it's actually the it's it's the worst combined measure that we have it's very
problematic. So, um, I think we need to really take a step back and, and really think about
what we're being critical of. Maybe it's like point the finger back to, um, look, I'm a, I am
a manual therapy trained therapist. Um, I love manual therapy. Um, I, I think for the right case,
it gets us places um I think there have been times so you're mentioning this concept of of
manual therapy being sort of the trend and I I think there have been times where trends were the
exercise focused and then we kind of went psych focused um where we've done essentially just talk
therapy and no touch or exercise therapy and think the pendulum kind of always swings um
Um, but, but I think, or at least that's how it gets kind of polarized in social media.
And I think that if you really talk to clinicians, it's not really this, we only do talk therapy
or we only do manual therapy, but it just gets polarized that way.
That's what I suspect.
That's my hunch.
Um, but you know, you notice this on courses and conference circuits as well.
It's not just social media.
I keep saying social media, um, but, um, but I think that what this systematic review
has taught me is that we're not doing a good job of understanding and properly using outcome
measures, which has the downstream effect of not getting to the right treatment efficiently and
potentially adds a longer time to that positive outcome, as I mentioned. So there is a tendency
to over-utilize treatment trends of the hour and leave the others behind. And I think if we can
really focus on doing a good assessment based on multiple measures across the spectrum so
psychosocial questionnaires or psychosexual measures manual testing testing using other
objective measures musculoskeletal pelvic hip pelvic SI joint whatever and then interpret that
appropriately so this is a big problem is the interpretation of that will arrive at the best
approach so manual therapy tends to be a lot of passive stretching type techniques and if you
tested the active component and it was negative and your combined measure still showed stiffness
meaning the passive tone was greater then that is absolutely the right treatment manual therapy
is 100 the right treatment um so and maybe that manual therapy for one person is is the right
treatment and mindfulness meditation is the right treatment and another person needs biofeedback
because they had higher activity and this other person tested positive on these psychosexual
measures for instance um and or you know a combination of these treatments where the
we would treat you know the predominant aspect of the presentation if everything was testing
positive what's testing the most positive right so i think we need to be careful not to get into
practice patterns or habits where we swing too far in any direction and stay there for every case
that's the problem. We need to consider the story of the person in front of us. We need to use the
tools, the outcome measures, arm ourselves with a deep understanding of those. And unfortunately,
this is not where our training system is at the moment. And I've just heard a lot of conversations
about this, suggesting, as we talked about, that, you know, EMG is a waste of time, but are they?
if it gives us the information we need to get to the treatment quicker.
Well said. Well said. That's beautiful. Be flexible, individualized, science-based,
and yeah, don't get stuck in the shiny loud noisemaker over here that
all that like shiny stuff. Don't get too caught up with the shiny stuff. This stuff that looks
very enticing and exciting right go back to the simple keep it simple we you know biology is
complex enough but the treatments i always say the treatments don't have to be they don't have to be
um this is beautiful i i am so thankful for you uh being on the show today sharing your expertise
your wisdom and your message of of helping clinicians really start to shift the way that
they practice and the way that they and what they offer really to their to their patients and you're
right we could be we could do a better job of being more efficient and if we use our outcome
measures in the way that we not just to submit it for insurance or to do it because our institution
is telling us to do and then never retest it again. And I'll never use it again. We just do
it once, you know, um, I fall in that trap too, but using appropriate measures, um, I, I, I think
we would be, we would help people sooner, faster, and they wouldn't have to really rely on us for
so long. Um, that's really the goal, honestly, that they don't need us anymore. So, um, you,
One thing that you had mentioned really quickly is the psychosexual measures.
Do you have any favorite ones that you like to use or that you use with your patients?
I've not spent a lot of time investigating those.
Those are more recent thoughts and conversations that I've had.
There's a paper by Pandoa 2021.
There was a systematic review, or I think it's just a review report, part one and part two, and they highlight these measures.
So they highlight the measures that I've talked about and then also have additionally added these psychosexual measures, and I've not spent much time in that space.
But it is certainly something that I think we need to be considering because what do we do if this sort of construct that we've been living in for a long time of tone causes pain and pain causes tone breaks apart?
and and then what what is the cause and and we need to start looking at these other concepts
is it lifestyle factors is it perfusion it's one of my favorite topics is it sleep um sleep of
course goes into the category of lifestyle medicine um looking at sleep right now which
is really um i think going to be cool um and tone goes away when we sleep it should
um and so if we're not sleeping what happens to our tone um so so we need to really and then of
course other musculoskeletal factors but um we hormonal factors we need to start looking at all
of this more um and really quickly briefly perfusion you smiled and then you said i really
love that could you explain that to to us yeah um well i i think we've all and i'm sure i would
imagine you've talked about this on the podcast but you know we talk about um the penis being
the barometer for the heart right ah yeah um and what we're talking about there is atherosclerotic
plaques in the arteries going to the penis. Um, and that actually being an indicator of maybe
something more, um, systemic, right. And, um, if you look at, um, populations of younger people,
the first place that we start to see plaques form, um, is in the abdomen. And if you think
about the downstream effects that arteries start bigger and then they get smaller, smaller,
smaller. And, um, and so I'm really interested in this idea of getting oxygen to, to tissue
and how that relates to, uh, lifestyle medicine, um, diets, exercise, and, um,
have some theories about, about that. But I, one of the first things I do a very extensive, um,
diet, um, assessment. I think a lot of us do. Um, I do a lot of education there. Um, but I
kind of base it around, um, concepts of, of perfusion and, uh, look, we know we have had
this discussion for a lot of years about ischemia and how that relates to pelvic pain and pedendal
rupture. Right. But we don't talk about it in the context of atherosclerosis in the pelvic region
as much and we need to go there sciatica that's one of the arteries that's downstream from where
we know plaques form first um in youth so um low back pain everything right so we need to look at
that oh my gosh oh so exciting i am so tickled this is wonderful i have to say i'm like i'm
kicking out over here i love it thank you you're speaking my love language this is wonderful we
again i i can't i'm speaking for myself i cannot wait to read more of the research that's that's
going to be coming out and all that you are all doing with your team there and uh yeah such a
pleasure having you on the show and thank you so much nice chatting with you suzy good luck
yeah thank you and rachel if folks wanted to connect with you follow your work where would
be the best way to connect with you? I'm probably the most active on Instagram and my Instagram
handle. Do you call it that? So terrible at social media. I think so. I don't. I'm also terrible.
Pelvic.fit with three I's. Pelvic.fit.facts. And the goal of that Instagram account is to
really sort of bridge research and clinicians, but patients are certainly welcome to join into
the conversation. It's just really boring. I'm not a Canva person. So like, if you want Canva
images, don't follow me. Don't come for the aesthetics. Is that what you're saying?
Come for the facts, come for the knowledge, come for the truth, but don't come for the facts.
i love it yeah that's that's awesome
a cute photo take shirts
oh this is awesome great yes yes thank you um we will make sure to
link your your your your research your instagram handle um and and certainly your your full bio
and everything on the show notes in the show notes as well so yeah thanks yeah i'm also on
twitter at um rachel underscore warren but that seems to be kind of where researchers hang out
and i don't there as much so no that's awesome that's great yeah we do you know we have this
show is a combination of of general public but also of the um clinicians and and health
professionals so yeah no that's great anywhere that they can connect with you and your research
which I think is mind blowing. It's really awesome. And I'm really inspired, um, to really
change some things in my own practice to, to keep up with what we're learning. I am, I'm really
inspired. And to be honest, I'm going to be looking at, uh, some, uh, EMG machines for your
opinion. Um, yeah, I'm going to be looking at that. I think it's great. And, and yeah, no,
this has been very inspirational and I think you're right. I think we can do a better job
being more efficient clinicians and yeah yeah for your phd that's right thank you rachel plug plug
awesome awesome well thank you again and to all of our viewers and listeners out there i hope you
enjoyed this show as always and loving wellness for your pelvis this is suzy gronski until next
time thanks for listening to today's episode be sure to visit my website drsuzyg.com for show
notes and related resources on today's topic if you like what you're hearing
head on over to YouTube and subscribe to my channel on my youtube channel you'll
find content related to sex pelvic health and expert interviews for men if
you got a question or a topic that you'd like me to answer on my channel be sure
to type it in the comment box below
